AquaCelle logo with stylized overlapping blue and teal circles and the company name below.

Omega-3

Supercharge Bioavailability

AquaCelle® Omega-3 is specifically designed to enhance bioavailability of DHA+EPA in fish, krill and algal oil.

Scientifically proven and clinically tested in humans, AquaCelle® Omega-3 dramatically improves absorption, while increasing omega-3 uptake by over 600%.

AquaCelle® Omega-3 advantages

  • enhanced bioavailability over x6

  • an option for a smaller dose size

  • clinically proven

  • improved EPA + DHA absorption

  • counteracts unpleasant “fishy” reflux

  • can be included in water-based formulations

  • stable formulation

  • Australian developed and made

  • utilises patent technology

Two transparent glass beakers, one filled with water and the other empty, placed on a black surface against a white background.
Learn more

AquaCelle® Omega-3 improves EPA and DHA bioavailability

This study assessed the ability of a self-emulsifying drug delivery system (SEDDS), AquaCelle®, as an additive to enhance the oral absorption of Omega-3 ethyl esters (EE) in healthy subjects under low-fat diet conditions.

Illustration of a human digestive system showing oral intake of fish oil, with a diagram of SEDDS plus fish oil and a graph depicting the effects of fish oil and SEDDS on plasma DHA levels and oral bioavailability over 24 hours. AquaCelle
Read more
Logo of the Australian Government Department of Industry, Innovation and Science featuring a kangaroo and emu above a shield.

NSW Department of Industry Tech Connections Voucher granted for AquaCelle® Omega study.